Read More

Neuronetics Receives FDA 510(k) Clearance For NeuroSite Coil Placement Accessory That Simplifies Measurement And Coil Positioning During Neurostar Transcranial Magnetic Stimulation Treatments

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the

STIM

Read More

CNS Pharmaceuticals Announces Successful Interim Analysis Of Efficacy And Safety Data In Potentially Pivotal Study Of Berubicin; Independent DSMB Recommends Continuing Clinical Trial Of Berubicin Without Modification

Independent DSMB recommends continuing clinical trial of Berubicin without modificationEnrollment expected to be complete in early Q1 2024HOUSTON, TX / ACCESSWIRE / December 18, 2023 / CNS Pharmaceuticals, Inc.

CNSP